Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2020 and Provide a Corporate Strategic Update


RANCHO CORDOVA, Calif., Aug. 5, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the second quarter ended June 30, 2020 and provide a corporate strategic update on Wednesday, August 12, 2020 after the close of trading.  A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET.

To participate in the conference call, please dial 1-844-889-4331 (domestic), 1-412-380-7406 (international) or 1-866-605-3852 (Canada). To access a live webcast of the call, please visit: https://thermogenesis.com/investors/news-and-events/events-webcasts.

A webcast replay will be available on ThermoGenesis' website for three months by visiting the Investor page of the Company's website at www.thermogenesis.com.

About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpresstm platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.thermogenesis.com.

Company Contact:
Wendy Samford
916-858-5191
[email protected]

Investor Contact:
Paula Schwartz, Rx Communications
917-322-2216
[email protected]

SOURCE ThermoGenesis Holdings, Inc.


These press releases may also interest you

at 07:35
Ironwood Pharmaceuticals, Inc. , a GI-focused healthcare company, today announced positive, primary results up to Day 91 for its Phase II exploratory STARGAZE trial evaluating apraglutide in patients with steroid-refractory gastrointestinal acute...

at 07:35
The Real Brokerage Inc. , the fastest-growing, publicly traded brokerage, today announced that the Jon Campbell Team, formerly known as the Don Wenner Team, has joined the company. The team ranked as RealTrends' No. 1 Mega team in Pennsylvania and...

at 07:35
On March 21, xFusion Technologies International Co., Ltd. successfully hosted its Tech Summit 2024 and Partner Conference in Hong Kong. The conference focused on sharing industry trends and xFusion's product strategies centered around AI and green...

at 07:35
dentalcorp Holdings Ltd. ("dentalcorp" or the "Company") , Canada's largest and one of North America's fastest growing networks of dental practices, today announced that it will present at the following investor conferences: 2024 Bloom Burton & Co....

at 07:30
Quipt Home Medical Corp. (the "Company") ?, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders held on March 27, 2024...

at 07:30
LeddarTech Holdings Inc. ("LeddarTech") , an automotive software company that provides patented disruptive AI-based low-level sensor fusion and perception software technology, LeddarVisiontm, for ADAS, AD and parking applications, is pleased to...



News published on and distributed by: